Stephen Morse
Family Medicine · Bluffton, INNPI 1801234729
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 335 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,596 and has fallen 96.9% since, to $50 in 2024.
Across 335 payments — averaging $15.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$751
- AbbVie$639
- Amgen$629
- Lilly USA, LLC$552
- Novo Nordisk$500
- GSK$376
- plus $2K from 29 others
What the payments were for
- Food & beverage$5,201100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,201 in reported general payments places this provider in the 85th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 46 | $38,702 |
| JardianceEmpagliflozin | 28 | $29,348 |
| XareltoRivaroxaban | 18 | $14,759 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 28 | $13,323 |
| NamzaricMemantine Hcl/Donepezil Hcl | 13 | $8,815 |
| Pantoprazole Sodium | 107 | $1,506 |
| Atorvastatin Calcium | 171 | $1,355 |
| Valsartan | 31 | $1,054 |
| Metoprolol Succinate | 82 | $1,003 |
| Levothyroxine Sodium | 111 | $989 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 42 | $910 |
| Amlodipine Besylate | 138 | $885 |
| Omeprazole | 42 | $831 |
| Potassium Chloride | 19 | $708 |
| Gabapentin | 29 | $702 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $84 | $38,70246 claims |
| Boehringer IngelheimJardiance | $255 | $29,34828 claims |
| Johnson & JohnsonXarelto | $55 | $14,75918 claims |
| GSKAnoro Ellipta | $376 | $13,32328 claims |
| AbbVieNamzaric | $639 | $8,81513 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $16 | $989111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Bluffton
- Richard TannerIndianapolis$1.6M
- James AndryBloomington$715K
- Richard FeldmanIndianapolis$476K
- Anthony InzerelloEvansville$308K
- Joe BanksIndianapolis$294K
- Steven GatewoodElwood$281K
- Shekar PushpalaCarmel$239K
- Victoria MoyerKokomo$188K
- Thomas KintanarFort Wayne$185K
- Jeffrey HiltzMuncie$177K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.